BR112022018136A2 - Composições e métodos para tratar lesões de reperfusão ou hemorragia após terapia de recanalização - Google Patents
Composições e métodos para tratar lesões de reperfusão ou hemorragia após terapia de recanalizaçãoInfo
- Publication number
- BR112022018136A2 BR112022018136A2 BR112022018136A BR112022018136A BR112022018136A2 BR 112022018136 A2 BR112022018136 A2 BR 112022018136A2 BR 112022018136 A BR112022018136 A BR 112022018136A BR 112022018136 A BR112022018136 A BR 112022018136A BR 112022018136 A2 BR112022018136 A2 BR 112022018136A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- compositions
- hemorrhage
- thrombolytic drug
- reperfusion injuries
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062988187P | 2020-03-11 | 2020-03-11 | |
| PCT/IB2021/000136 WO2021181159A1 (en) | 2020-03-11 | 2021-03-10 | Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022018136A2 true BR112022018136A2 (pt) | 2022-10-25 |
Family
ID=77665492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022018136A BR112022018136A2 (pt) | 2020-03-11 | 2021-03-10 | Composições e métodos para tratar lesões de reperfusão ou hemorragia após terapia de recanalização |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11826329B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4117648A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7870252B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230010187A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115515573A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021233206A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022018136A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3174709A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2022014343A2 (cg-RX-API-DMAC7.html) |
| IL (2) | IL296288B2 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2022011214A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021181159A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12285182B2 (en) | 2018-10-10 | 2025-04-29 | Innova Vascular, Inc. | Devices and methods for removing an embolus |
| US11826329B2 (en) | 2020-03-11 | 2023-11-28 | Gnt Pharma Co., Ltd. | Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy |
| CN113995723B (zh) * | 2020-07-27 | 2025-02-18 | 浙江普洛家园药业有限公司 | 一种索法地尔冻干粉针剂的制备方法及其产品和用途 |
| KR20240142433A (ko) * | 2021-12-28 | 2024-09-30 | 주식회사 지엔티파마 | 폐 장애를 치료하기 위한 조성물 및 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100545745B1 (ko) * | 2002-06-19 | 2006-01-24 | 주식회사 뉴로테크 | 테트라플루오로벤질 유도체 및 이를 함유하는 급성 및퇴행성 뇌신경계 질환의 예방 및 치료용 약학적 조성물 |
| KR100522188B1 (ko) * | 2003-01-20 | 2005-10-18 | 주식회사 뉴로테크 | 뉴로트로핀에 의해 유도되는 세포괴사 억제 방법 |
| KR20060121721A (ko) * | 2005-05-23 | 2006-11-29 | 주식회사 중외제약 | 테트라플루오로벤질 유도체 또는 그의 염을 함유하는주사제용 조성물 |
| KR20060121768A (ko) * | 2005-05-25 | 2006-11-29 | 주식회사 중외제약 | 테트라플루오로벤질 아닐린 유도체 및 이의 약학적으로허용가능한 염 화합물의 제조방법 |
| KR101523345B1 (ko) * | 2008-04-28 | 2015-05-28 | 주식회사 지엔티파마 | 재관류 손상의 치료 또는 예방용 약학 조성물 |
| CN102617383A (zh) | 2012-03-20 | 2012-08-01 | 横店集团家园化工有限公司 | 索法地尔晶型、制备方法及包含索法地尔晶体的无菌粉末 |
| JP2018502894A (ja) | 2015-01-27 | 2018-02-01 | アストラゼネカ アクチボラグ | 心筋梗塞の病歴がある患者においてアテローム血栓性イベントを治療または予防する方法 |
| US11826329B2 (en) | 2020-03-11 | 2023-11-28 | Gnt Pharma Co., Ltd. | Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy |
-
2021
- 2021-03-10 US US17/197,736 patent/US11826329B2/en active Active
- 2021-03-10 WO PCT/IB2021/000136 patent/WO2021181159A1/en not_active Ceased
- 2021-03-10 CA CA3174709A patent/CA3174709A1/en active Pending
- 2021-03-10 JP JP2022554288A patent/JP7870252B2/ja active Active
- 2021-03-10 AU AU2021233206A patent/AU2021233206A1/en active Pending
- 2021-03-10 CN CN202180032761.3A patent/CN115515573A/zh active Pending
- 2021-03-10 KR KR1020227034966A patent/KR20230010187A/ko active Pending
- 2021-03-10 EP EP21768391.1A patent/EP4117648A4/en active Pending
- 2021-03-10 MX MX2022011214A patent/MX2022011214A/es unknown
- 2021-03-10 IL IL296288A patent/IL296288B2/en unknown
- 2021-03-10 BR BR112022018136A patent/BR112022018136A2/pt unknown
- 2021-03-10 IL IL309923A patent/IL309923A/en unknown
-
2022
- 2022-09-09 MX MX2025012439A patent/MX2025012439A/es unknown
- 2022-10-07 CO CONC2022/0014343A patent/CO2022014343A2/es unknown
-
2023
- 2023-08-21 US US18/235,986 patent/US12433861B2/en active Active
-
2025
- 2025-09-10 US US19/324,355 patent/US20260027076A1/en active Pending
-
2026
- 2026-02-06 JP JP2026018547A patent/JP2026082994A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL296288B1 (en) | 2024-02-01 |
| CA3174709A1 (en) | 2021-09-16 |
| US20260027076A1 (en) | 2026-01-29 |
| EP4117648A1 (en) | 2023-01-18 |
| EP4117648A4 (en) | 2024-05-29 |
| JP7870252B2 (ja) | 2026-06-04 |
| IL296288A (en) | 2022-11-01 |
| CO2022014343A2 (es) | 2023-02-16 |
| JP2023517566A (ja) | 2023-04-26 |
| US20210283080A1 (en) | 2021-09-16 |
| CN115515573A (zh) | 2022-12-23 |
| IL309923A (en) | 2024-03-01 |
| IL296288B2 (en) | 2024-06-01 |
| US11826329B2 (en) | 2023-11-28 |
| MX2022011214A (es) | 2022-10-07 |
| AU2021233206A1 (en) | 2022-10-06 |
| WO2021181159A1 (en) | 2021-09-16 |
| JP2026082994A (ja) | 2026-05-19 |
| US20230390231A1 (en) | 2023-12-07 |
| KR20230010187A (ko) | 2023-01-18 |
| US12433861B2 (en) | 2025-10-07 |
| MX2025012439A (es) | 2025-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022011214A (es) | Composiciones y metodos para el tratamiento de lesion por reperfusion o hemorragia despues de la terapia de recanalizacion. | |
| BR112016025997A8 (pt) | compostos para tratamento de doenças e lesões oftalmológicas, uma composição farmacêutica e uma formulação oftálmica | |
| WO2008131941A1 (en) | Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation | |
| López-López et al. | Application of cantharidin, podophyllotoxin, and salicylic acid in recalcitrant plantar warts. A preliminary study | |
| MX2023000610A (es) | Inhibidor de trpv4 como agente terapeutico para enfermedades oculares. | |
| Sarkaki et al. | Therapeutic effects of resveratrol on ischemia–reperfusion injury in the nervous system | |
| KR100951542B1 (ko) | 방광 자극 및 과민성 방광을 치료하기 위한 약제학적 조성물 | |
| Aguilera-Roig et al. | Tranexamic acid in orthopedic surgery | |
| CR20250205A (es) | Derivados de 2-amino-n-(4-amino-3,4-dioxo-1-(2-oxopirrolidin-3-il) butan-2-il) benzamida como inhibidores de proteasa para tratar o prevenir la infección por coronavirus. | |
| Zeng et al. | Activation of inflammasomes and relevant modulators for the treatment of microglia-mediated neuroinflammation in ischemic stroke | |
| AU2014210332B2 (en) | Method of treating fibrosis in skeletal muscle tissue | |
| RU2417765C2 (ru) | Способ лечения подкожной гематомы, образовавшейся вследствие укуса животного | |
| KR20160094345A (ko) | 베르베논 유도체를 포함하는 재관류 시술의 부작용을 감소 또는 예방하기 위한 조성물 | |
| DeRossi et al. | Efficacy of concurrent epidural administration of neostigmine and lidocaine for perineal analgesia in geldings | |
| Sonune et al. | Comparative study of ultrasound guided supra-scapular nerve block versus intra-articular steroid injection in frozen shoulder | |
| Kurt et al. | Effects of adding alfentanil or atracurium to lidocaine solution for intravenous regional anaesthesia | |
| Viswanathan et al. | Intraosseous regional antibiotic prophylaxis in total joint arthroplasty (TJA): Systematic review and meta-analysis | |
| Su et al. | Comparison between periarticular analgesia versus intraarticular injection for effectiveness and safety after total knee arthroplasty | |
| CY1113544T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει ενα συνδυασμο που σχηματιζεται απο τον αντιμικροβιακο παραγοντα σιπροφλοξασινη και τον αντιοξειδωτικο παραγοντα ασκορβικο οξυ για τη θεραπεια λοιμωξεων του ουροποιητικου συστηματος | |
| CA2785303A1 (en) | Method for the non-surgical treatment of lipodystrophy in a retrovirus-infected individual | |
| WO2022007833A1 (zh) | 一种组合物在治疗脑卒中的用途 | |
| Srinivasan et al. | Ultrasound guided 4 in 1 block for managing postoperative pain in arthroscopic knee surgery | |
| Jadhav et al. | A prospective, multicentric study to determine the safety and effectiveness of fixed-dose combination of camylofin dihydrochloride and nimesulide in patients presenting with acute colicky abdominal pain in India | |
| CZ2003957A3 (cs) | Použití argininu při přípravě léků pro prevenci a léčení vedlejších účinků spojených s itravenózním podáním farmaceutických preparátů | |
| Rachiele et al. | Complication of Arterial Drug Injections: Treading Cautiously Beyond Primum Non-Nocere |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B154 | Notification of filing of divisional application [chapter 15.50 patent gazette] |
Free format text: O PEDIDO FOI DIVIDIDO NO BR122025026201-3 PROTOCOLO 870250109070 EM 27/11/2025 17:53. |